These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19150063)

  • 41. A CHO/fibre diet reduces and a MUFA diet increases postprandial lipaemia in type 2 diabetes: no supplementary effects of low-volume physical training.
    Bozzetto L; Annuzzi G; Costabile G; Costagliola L; Giorgini M; Alderisio A; Strazzullo A; Patti L; Cipriano P; Mangione A; Vitelli A; Vigorito C; Riccardi G; Rivellese AA
    Acta Diabetol; 2014; 51(3):385-93. PubMed ID: 24132660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.
    Nordøy A; Svensson B; Hansen JB
    J Thromb Haemost; 2003 Apr; 1(4):690-7. PubMed ID: 12871402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance.
    Park Y; Harris WS
    J Lipid Res; 2003 Mar; 44(3):455-63. PubMed ID: 12562865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation.
    Schirmer SH; Werner CM; Binder SB; Faas ME; Custodis F; Böhm M; Laufs U
    Atherosclerosis; 2012 Nov; 225(1):166-72. PubMed ID: 23017356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incremental area under response curve more accurately describes the triglyceride response to an oral fat load in both healthy and type 2 diabetic subjects.
    Carstensen M; Thomsen C; Hermansen K
    Metabolism; 2003 Aug; 52(8):1034-7. PubMed ID: 12898469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity and free fatty acids: double trouble.
    Castro Cabezas M; Halkes CJ; Erkelens DW
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):134-42. PubMed ID: 11434190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state.
    Roche HM; Gibney MJ
    Lipids; 1999; 34 Suppl():S259-65. PubMed ID: 10419173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postprandial Hyperlipidemia and Remnant Lipoproteins.
    Masuda D; Yamashita S
    J Atheroscler Thromb; 2017 Feb; 24(2):95-109. PubMed ID: 27829582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discrepancy Between Fasting Flow-Mediated Dilation and Parameter of Lipids in Blood: A Randomized Exploratory Study of the Effect of Omega-3 Fatty Acid Ethyl Esters on Vascular Endothelial Function in Patients With Hyperlipidemia.
    Teramoto T; Shibata H; Suzaki Y; Matsui S; Uemura N; Tomiyama H; Yamashina A
    Adv Ther; 2020 May; 37(5):2169-2183. PubMed ID: 32200533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SORT1 protective allele is associated with attenuated postprandial: lipaemia in young adults.
    Connors KE; Karlos AE; Gnatiuk EA; Shearer J; Reimer RA; Hittel DS
    Circ Cardiovasc Genet; 2014 Oct; 7(5):576-82. PubMed ID: 25042869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-prandial lipoprotein metabolism in nephrotic syndrome.
    Warwick GL; Packard CJ; Stewart JP; Watson TD; Burns L; Boulton-Jones JM; Shepherd J
    Eur J Clin Invest; 1992 Dec; 22(12):813-20. PubMed ID: 1478253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease.
    Ntyintyane LM; Panz VR; Raal FJ; Gill GV
    QJM; 2008 Feb; 101(2):111-9. PubMed ID: 18194974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise plus n-3 fatty acids: additive effect on postprandial lipemia.
    Smith BK; Sun GY; Donahue OM; Thomas TR
    Metabolism; 2004 Oct; 53(10):1365-71. PubMed ID: 15375796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of postprandial lipaemia.
    Kolovou GD; Anagnostopoulou KK; Daskalopoulou SS; Mikhailidis DP; Cokkinos DV
    Curr Med Chem; 2005; 12(17):1931-45. PubMed ID: 16101498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia.
    Nordoy A; Bonaa KH; Sandset PM; Hansen JB; Nilsen H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):259-65. PubMed ID: 10634827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chylomicron remnants are increased in the postprandial state in CD36 deficiency.
    Masuda D; Hirano K; Oku H; Sandoval JC; Kawase R; Yuasa-Kawase M; Yamashita Y; Takada M; Tsubakio-Yamamoto K; Tochino Y; Koseki M; Matsuura F; Nishida M; Kawamoto T; Ishigami M; Hori M; Shimomura I; Yamashita S
    J Lipid Res; 2009 May; 50(5):999-1011. PubMed ID: 18753675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia.
    Schmidt EB; Kristensen SD; De Caterina R; Illingworth DR
    Atherosclerosis; 1993 Nov; 103(2):107-21. PubMed ID: 8292089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Correction of atherogenic exogenously-induced postprandial hyperlipidemia with pravastatin].
    Bubnova MG; Aronov DM; Perova NV; Olfer'ev AM; Golubev MA; Mel'kina OE; Zhasminova VG
    Kardiologiia; 2002; 42(1):27-32. PubMed ID: 12494220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia.
    Desmarchelier C; Borel P; Lairon D; Maraninchi M; Valéro R
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31181761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The postprandial situation as a pro-inflammatory condition.
    de Vries MA; Klop B; Eskes SA; van der Loos TL; Klessens-Godfroy FJ; Wiebolt J; Janssen HW; Westerman EM; Castro Cabezas M
    Clin Investig Arterioscler; 2014; 26(4):184-92. PubMed ID: 24866730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.